The page is the record's research on the issuer — no analyst, no rating, no view. # Seaport Therapeutics, Inc. (NASDAQ: SPTX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Seaport Therapeutics, Inc., listed on NASDAQ under ticker SPTX, with ISIN US81221K1088; the LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 57 filings in the twelve months to 2026-11-08, across 18 filing days. Of these, 33 are directors' dealings, 13 are regulatory filings, 6 are results, 4 are prospectuses and 1 is ad hoc. The median gap between filing days is 9 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is dated 2026-11-04 and is a directors' dealings filing, 4 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The NASDAQ median filing count is 52 and the sector median is 63.0. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none), and its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds two listing lines, dated 2026-04-28 and 2026-04-30. It holds no delisting, no name change and no domicile change; the domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable: the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002042347.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/SPTX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/SPTX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/SPTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp